F M Al Badri1,2, R Baatjies1,3, Mohamed F Jeebhay4. 1. Occupational Medicine Division and Centre for Environmental & Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town, Room 4. 45, Fourth Level, Falmouth Building, Anzio Road, Observatory, Cape Town, 7925, South Africa. 2. Occupational Medicine Department, Armed Forces Medical Services, Muscat, Oman. 3. Department of Environmental and Occupational Studies, Cape Peninsula University of Technology (CPUT), Cape Town, South Africa. 4. Occupational Medicine Division and Centre for Environmental & Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town, Room 4. 45, Fourth Level, Falmouth Building, Anzio Road, Observatory, Cape Town, 7925, South Africa. Mohamed.Jeebhay@uct.ac.za.
Abstract
PURPOSE: To assess the impact of an intervention for baker's allergy and asthma in supermarket bakeries. METHODS: A group randomised trial conducted in 31 bakeries (n = 337 bakers) that were randomly assigned to one of two intervention groups (n = 244 bakers) and a control group (n = 93 bakers). Health data collected prior to and 1-year after the intervention included information obtained from an ECRHS questionnaire; tests for atopy and serum-specific IgE to cereal flours; fractional exhaled nitric oxide (FeNO). Data from the two intervention groups were combined to form one intervention group for purposes of the statistical analysis. RESULTS: At 1 year of follow-up, the incidence and level of decline of work-related ocular-nasal and chest symptoms, sensitisation status and elevated FeNO (FeNO > 25 ppb) was similar in both intervention and control groups. The mean FeNO difference was also similar across both groups (2.2 ppb vs 1.7 ppb, p = 0.86). In those with FeNO > 25 ppb at baseline, the decline was greater in the intervention compared to control group (16.9 ppb vs 7.7 ppb, p = 0.24). Multivariate logistic regression models (adjusting for smoking, baseline sensitisation to cereal flour, baseline FeNO > 25 ppb) did not demonstrate an appreciable FeNO decline (≥ 10%) in the intervention compared to control group. However, stratification by the presence of work-related ocular-nasal symptoms in bakers at baseline demonstrated a significant FeNO decline (≥ 10%) in the intervention compared to the control group (OR 3.73, CI 1.22-11.42). CONCLUSION: This study demonstrates some evidence of an intervention effect on FeNO 1 year after an intervention, particularly in bakers with work-related ocular-nasal symptoms.
RCT Entities:
PURPOSE: To assess the impact of an intervention for baker's allergy and asthma in supermarket bakeries. METHODS: A group randomised trial conducted in 31 bakeries (n = 337 bakers) that were randomly assigned to one of two intervention groups (n = 244 bakers) and a control group (n = 93 bakers). Health data collected prior to and 1-year after the intervention included information obtained from an ECRHS questionnaire; tests for atopy and serum-specific IgE to cereal flours; fractional exhaled nitric oxide (FeNO). Data from the two intervention groups were combined to form one intervention group for purposes of the statistical analysis. RESULTS: At 1 year of follow-up, the incidence and level of decline of work-related ocular-nasal and chest symptoms, sensitisation status and elevated FeNO (FeNO > 25 ppb) was similar in both intervention and control groups. The mean FeNO difference was also similar across both groups (2.2 ppb vs 1.7 ppb, p = 0.86). In those with FeNO > 25 ppb at baseline, the decline was greater in the intervention compared to control group (16.9 ppb vs 7.7 ppb, p = 0.24). Multivariate logistic regression models (adjusting for smoking, baseline sensitisation to cereal flour, baseline FeNO > 25 ppb) did not demonstrate an appreciable FeNO decline (≥ 10%) in the intervention compared to control group. However, stratification by the presence of work-related ocular-nasal symptoms in bakers at baseline demonstrated a significant FeNO decline (≥ 10%) in the intervention compared to the control group (OR 3.73, CI 1.22-11.42). CONCLUSION: This study demonstrates some evidence of an intervention effect on FeNO 1 year after an intervention, particularly in bakers with work-related ocular-nasal symptoms.
Authors: P L Piirilä; H Nordman; H M Keskinen; R Luukkonen; S P Salo; T O Tuomi; M Tuppurainen Journal: Am J Respir Crit Care Med Date: 2000-08 Impact factor: 21.405
Authors: Athena T Jolly; Julia E Klees; Karin A Pacheco; Tee L Guidotti; Howard M Kipen; Jeremy J Biggs; Mark H Hyman; Bruce K Bohnker; Matthew S Thiese; Kurt T Hegmann; Philip Harber Journal: J Occup Environ Med Date: 2015-10 Impact factor: 2.162
Authors: Roslynn Baatjies; Tim Meijster; Andreas Lopata; Ingrid Sander; Monika Raulf-Heimsoth; Dick Heederik; Mohamed Jeebhay Journal: Ann Occup Hyg Date: 2010-03-03
Authors: Gerda J de Groene; Teake M Pal; Jeremy Beach; Susan M Tarlo; Dick Spreeuwers; Monique Hw Frings-Dresen; Stefano Mattioli; Jos H Verbeek Journal: Cochrane Database Syst Rev Date: 2011-05-11
Authors: Roslynn Baatjies; Tim Meijster; Dick Heederik; Ingrid Sander; Mohamed F Jeebhay Journal: Occup Environ Med Date: 2014-06-04 Impact factor: 4.402
Authors: G Moscato; O Vandenplas; R Gerth Van Wijk; J L Malo; S Quirce; J Walusiak; R Castano; H De Groot; I Folletti; D Gautrin; M R Yacoub; L Perfetti; A Siracusa Journal: Allergy Date: 2008-08 Impact factor: 13.146